0.00
price down icon100.00%   -0.263
after-market  시간 외 거래:  .2629  0.2629   +
loading

Applied Molecular Transport Inc 주식(AMTI)의 최신 뉴스

Biopharma Layoff Tracker 2024: Erasca, Bolt, Tenaya and More Cut Staff - BioSpace

pulisher
BioSpace

Biopharma Layoff Tracker 2024: Erasca, Bolt, Tenaya and More Cut Staff - BioSpace

pulisher
BioSpace

Biopharma Layoff Tracker 2024: Erasca, Bolt, Tenaya and More Cut Staff - BioSpace

pulisher
BioSpace

Biopharma Layoff Tracker 2024: Erasca, Bolt, Tenaya and More Cut Staff - BioSpace

pulisher
BioSpace

Biopharma Layoff Tracker 2024: Bolt, Tenaya, BioMarin and More Cut Staff - BioSpace

pulisher
BioSpace

Did Applied Molecular Transport Inc. (NASDAQ:AMTI) Insiders Buy Up More Shares? - Yahoo Lifestyle Australia

pulisher
Yahoo Lifestyle Australia

Inflammatory Bowel Disease Market To Exhibit Significant Growth by 2032, Predicts DelveInsight | Key Companies ... - GlobeNewswire

pulisher
GlobeNewswire

Inflammatory Bowel Disease Market To Exhibit Significant Growth by 2032, Predicts DelveInsight | Key Companies ... - GlobeNewswire

pulisher
GlobeNewswire

Finance Watch: More Job Cuts As Companies Prioritize Cash Conservation - Scrip

pulisher
Scrip

Fierce Biotech M&A Tracker 2023: BMS, AbbVie drop billions for neuropsychiatry biotechs - Fierce Biotech

pulisher
Fierce Biotech

APPLIED MOLECULAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC ... - Business Wire

pulisher
Business Wire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Intercept ... - GlobeNewswire

pulisher
GlobeNewswire

This biotech went public 3 years ago at $14 per share. Here's how its stock cratered to 27 cents - San Francisco ... - The Business Journals

pulisher
The Business Journals

Why Faraday Future Intelligent Electric Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving - Benzinga

pulisher
Benzinga

Applied Molecular stock falls on merger with Cyclo Therapeutics - Seeking Alpha

pulisher
Seeking Alpha

Why NextGen Healthcare Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket - Addex Ther - Benzinga

pulisher
Benzinga

Wake Up Call: Law Firm Accused of Mismanaging Harassment Cases - Bloomberg Law

pulisher
Bloomberg Law

Allogene Therapeutics Appoints Earl Douglas as General Counsel - GlobeNewswire

pulisher
GlobeNewswire

Regulation of molecular transport in polymer membranes with voltage-controlled pore size at the angstrom scale - Nature.com

pulisher
Nature.com

Out of options: Infinity facing bankruptcy if MEI merger falls through - Fierce Biotech

pulisher
Fierce Biotech

Applied Molecular Transport CEO exits amid job cuts - San Francisco Business Times - The Business Journals

pulisher
The Business Journals

Coherus Biosciences, Applied Molecular Transport among latest biotechs to cut jobs - San Francisco Business Times - The Business Journals

pulisher
The Business Journals

Has CRISPR Therapeutics (CRSP) Outpaced Other Medical Stocks This Year? - Yahoo Canada Shine On

pulisher
Yahoo Canada Shine On

Glucagon Like Peptide 2 Receptor (GLP2R) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and ... - GlobalData

pulisher
GlobalData

10 Penny Stocks With > 1000% Upside - Barchart

pulisher
Barchart

Aquestive CEO departs with seizure med in limbo - Fierce Biotech

pulisher
Fierce Biotech

Applied Molecular co-founder exits amid 40% staff cut - Fierce Biotech

pulisher
Fierce Biotech

Top Opportunities in the Oversold Cannabis Stock Space (ACB, SGMD, TCNNF, CRLBF, SNDL, TLRY, CGC, MJ) - BP Journal

pulisher
BP Journal

Tiziana Life Sciences Ltd (NASDAQ: TLSA) Will Host the Key Opinion Leader Event - BP Journal

pulisher
BP Journal

J&J, following in Sanofi's footsteps, tasks i2o with oral delivery of large molecules - FiercePharma

pulisher
FiercePharma

Billionaire Peter Thiel: The man with the Golden Touch! - Value the Markets

pulisher
Value the Markets

Executive Women In Bio Selects Candidates for 2020 Boardroom Ready Program - GlobeNewswire

pulisher
GlobeNewswire

Jeff Seidel - Wilson Sonsini

pulisher
Wilson Sonsini

Vida Ventures Closes $600 Million Vida II Fund to Support Life Science Innovation - Business Wire

pulisher
Business Wire
$77.56
price up icon 0.77%
$149.40
price down icon 1.20%
$29.98
price up icon 1.11%
$172.85
price up icon 1.06%
$365.81
price down icon 2.87%
$90.61
price down icon 2.55%
자본화:     |  볼륨(24시간):